Dr. Daniel Wallace Appointed to Lupus Therapeutics Board

New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics  Board of Directors.   This governing body, which includes lupus patients, family members and scientists,  provides strategic insight and financial oversight to help Lupus Therapeutics achieve its mission –accelerate new ways to diagnose and treat lupus.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release

Recent Press Releases

Press Release
Accelerating Lupus Research with ThorSport Racing
ThorSport Racing & Ty Majeski Partner with Lupus Research Alliance to Drive Awareness for Lupus
ThorSport Racing and 2024 NASCAR Truck Series Champion Ty Majeski are teaming up with the Lupus Research Alliance (LRA) to launch a...
Press Release
The RRF and LRA Join Forces to Offer Funding to Address Lupus
The Rheumatology Research Foundation and the Lupus Research Alliance Join Forces to Offer Funding to Address Lupus
Amid ongoing fluctuations in federal research funding, a declining physician workforce, and increasing patient needs, the Rheumatology Research Foundation...
Press Release
2024 Awardees: Lupus Innovation Award
Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research
April 15, 2025
The Lupus Research Alliance (LRA) is proud to announce the recipients of this year’s Lupus Innovation Award (LIA), addressing...
Stay informed about events, research developments, and ways you can help. Sign up for updates